Shows
New York Public Health Nows3e02 Celebrating Progress and Charting the Path Forward: NYSDOH's Dr. David Holtgrave and Allan Clear Discuss New York State's Downward Overdose TrendsIn this episode of New York Public Health Now, Commissioner McDonald and Executive Deputy Commissioner Morne welcome the Department of Health's own Dr. David Holtgrave and Allan Clear to discuss the encouraging trends, indicating a decline in fatal drug overdoses across the state and nation. The nationally-recognized leaders explore the potential reasons behind this positive trend and outline strategies to maintain and accelerate the life-saving progress.This episode provides a comprehensive data-driven analysis of the overdose trends in New York, including both fatal and non-fatal incidents, and an in-depth conversation about the harm reduction initiatives spearheaded by...2024-09-2423 min
The Killing Drugs: Synthetic Opioids around the WorldHarm reduction strategies to tackle the fentanyl crisisIn this episode, host Vanda Felbab-Brown discusses the benefits and limitations of harm reduction approaches with experts Regina LaBelle and David Holtgrave, who discuss a wide scope of harm reduction measures, including naloxone provision, overdose prevention centers, and the importance and efficacy of client-centered and community-centered approaches. Felbab-Brown, LaBelle, and Holtgrave also explore the legal barriers and stigma that pose challenges to adopting these strategies in the United States. Show notes and transcript. Brought to you by the Brookings Podcast Network. Learn more at: Brookings.edu/KillingDrugs2024-09-0336 min
The Capitol PressroomHealth official joins state's fight against opioid epidemicAug. 30, 2024 - The state Department of Health has brought in a former Biden administration official, Dr. David Holtgrave, to help steer New York's response to the opioid epidemic.2024-08-3019 min
The latest stories fromHealth official joins state's fight against opioid epidemicAug. 30, 2024 - The state Department of Health has brought in a former Biden administration official, Dr. David Holtgrave, to help steer New York's response to the opioid epidemic.2024-08-3019 minNew York Public Health Nows3e01 Navigating the Opioid Crisis: A Conversation with Dr. David HoltgraveIn the season three opener of the New York Public Health Now podcast, Department of Health Commissioner Dr. Jim McDonald and Executive Deputy Commissioner Johanne Morne have a conversation with Dr. David Holtgrave, our newest senior policy advisor at the New York State Department of Health. The discussion delves into the department's efforts to address the ongoing opioid epidemic, with Dr. Holtgrave providing his expansive expertise and insights. The conversation covers topics such as the mechanics and history of opioid antagonists like naloxone, the emergence of alternatives like nalmefene, and the latest trends in fatal ov...2024-08-3037 min
New York State News and Info TrackerNew York's Multifaceted Narrative: A Political, Health, and Legal LandscapeNew York, a state rich in historical significance and bustling with contemporary life, continuously shapes its identity through political, health, and legal narratives. Recently, Robert Zimmerman, a New York delegate and former congressional candidate, made headlines during his appearance on NY1’s “Inside City Hall.” Zimmerman’s involvement in New York politics highlights the state's ongoing discourse around governance and public policy, echoing its reputation as a politically active state with a diverse array of opinions and strategies.In the health sector, New York has been at the forefront of managing public health challenges. Dr. David Holtgrave, serving as a spe...2024-08-2301 min
Anderson Cooper 360Pres. Trump defends use of hydroxychloroquine, says it “doesn’t harm you”Despite the FDA’s warning of serious side effects from taking hydroxychloroquine, the President of the United States has defended his decision to take the drug. David Holtgrave, a lead researcher in a hydroxychloroquine study, tells Anderson Cooper in their study they didn’t find a statistically significant benefit of the drug in terms of death rate or abnormal heart rhythms. Plus, Dr. Eric Topol, a cardiologist, adds that there is no sign of any efficacy by taking the anti-malaria drug but there is a sign of significant hazard.
Airdate: May 19, 20202020-05-2046 min
Anderson Cooper 360Pres. Trump defends use of hydroxychloroquine, says it “doesn’t harm you”Despite the FDA’s warning of serious side effects from taking hydroxychloroquine, the President of the United States has defended his decision to take the drug. David Holtgrave, a lead researcher in a hydroxychloroquine study, tells Anderson Cooper in their study they didn’t find a statistically significant benefit of the drug in terms of death rate or abnormal heart rhythms. Plus, Dr. Eric Topol, a cardiologist, adds that there is no sign of any efficacy by taking the anti-malaria drug but there is a sign of significant hazard.
Airdate: May 19, 2020To learn more...2020-05-2043 min